title: Acute urticaria induced by hyoscine butylbromide.
authors.affiliation: Rosario González-Mendiola c/ Villaamil 5, 2 degrees C 28039 Madrid Spain. chargomendi@excite.com
authors.forename: R
authors.initials: R
authors.lastname: González-Mendiola
authors.forename: C
authors.initials: C
authors.lastname: Sánchez Fernández
authors.forename: P
authors.initials: P
authors.lastname: Prieto Montaño
authors.forename: M
authors.initials: M
authors.lastname: Cuevas
authors.forename: M
authors.initials: M
authors.lastname: Ceña Delgado
authors.forename: M
authors.initials: M
authors.lastname: Sánchez Cano
mesh_terms: D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001064:Appendicitis / Q000150:complications; D002086:Butylscopolammonium Bromide / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000188:drug therapy; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007276:Injections, Intraventricular; D018727:Muscarinic Antagonists / Q000009:adverse effects*; D011241:Prednisone / Q000627:therapeutic use; D012882:Skin Tests / Q000379:methods; D014581:Urticaria / Q000139:chemically induced* / Q000188:drug therapy
chemical_list: D000305:Adrenal Cortex Hormones; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D018727:Muscarinic Antagonists; D002086:Butylscopolammonium Bromide; D011241:Prednisone